Fitch Releases Report on Dallas Independent School District, TX

AUSTIN, Texas--(BUSINESS WIRE)-- Fitch Ratings has published a report on Dallas Independent School District, TX.

The report is available at 'www.fitchratings.com'.

Additional information is available at 'www.fitchratings.com'.

Dallas Independent School District, Texas

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=867562

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150630006585/en/

Fitch Ratings
Rebecca Moses, +1-512-215-3739
Director
Fitch Ratings, Inc.
111 Congress Avenue
Austin, TX 78701
or
Jose Acosta, +1-512-215-3726
Senior Director
or
Media Relations:
Sandro Scenga, New York, +1 212-908-0278
[email protected]

Source: Fitch Ratings

You May Also Be Interested In

• Safe Pro Reports Record 1,336% Revenue Growth in Q2 2026 Driven by Multiple Government Contracts for AI-Powered Threat Detection and Mapping
• Sphere 3D Provides Business Update and Reports Second Quarter 2026 Financial Results
• SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate